InsiderClue
← All stocks

BlackRock Health Sciences Term Trust

BMEZ Net selling
CIK 0001785971 #2498 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$308.42K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$308.42K
4 of 4 sales
Net
−$308.42K
−$308.42K against sales at will

By person

6 insiders · 4 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Fairbairn Robert W
Director
—
$308.42K (4)
−$308.42K
0
$0.00
−100.0%
Accettella Christopher
Portfolio Manager
—
—
—
4,509
$67.46K
0.0%
McClements Kyle
Portfolio Manager
—
—
—
3,664
$54.81K
0.0%
Saba Capital Management, L.P. entity
10% owner
—
—
—
0
$0.00
−100.0%
Liu Xiang
Portfolio Manager
—
—
—
0
$0.00
—
Xie H Erin
Portfolio Manager
—
—
—
0
$0.00
—

No percentages here. BlackRock Health Sciences Term Trust reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

4
Insider
Date
Role
Action
Shares
Price
Amount
Fairbairn Robert W
19 Dec 2025
Director
Sell indirect
0
$14.96
$6.31
Fairbairn Robert W
19 Dec 2025
Director
Sell
0
$14.96
$6.31
Fairbairn Robert W
18 Dec 2025
Director
Sell indirect
10,294
$14.98
$154.20K
Fairbairn Robert W
18 Dec 2025
Director
Sell
10,294
$14.98
$154.20K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 52,908
History held since 30 Jan 2020